ABCL
Price
$11.32
Change
-$0.25 (-2.16%)
Updated
Aug 21 closing price
Capitalization
3.67B
78 days until earnings call
Intraday BUY SELL Signals
OABI
Price
$4.33
Change
+$0.03 (+0.70%)
Updated
Aug 21 closing price
Capitalization
629.54M
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs OABI

ABCL vs OABI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. OABI commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and OABI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 24, 2026
Stock price -- (ABCL: $11.32 vs. OABI: $4.33)
Brand notoriety: ABCL and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 49% vs. OABI: 167%
Market capitalization -- ABCL: $3.67B vs. OABI: $629.54M
ABCL [@Biotechnology] is valued at $3.67B. OABI’s [@Biotechnology] market capitalization is $629.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, OABI is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while OABI’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • OABI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABCL and OABI are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -0.53% price change this week, while OABI (@Biotechnology) price change was +28.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

OABI is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($3.67B) has a higher market cap than OABI($630M). ABCL YTD gains are higher at: 230.994 vs. OABI (134.054). OABI has higher annual earnings (EBITDA): -33.73M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. OABI (49.1M). OABI has less debt than ABCL: OABI (19.7M) vs ABCL (140M). ABCL has higher revenues than OABI: ABCL (79.2M) vs OABI (28.9M).
ABCLOABIABCL / OABI
Capitalization3.67B630M582%
EBITDA-167.02M-33.73M495%
Gain YTD230.994134.054172%
P/E RatioN/AN/A-
Revenue79.2M28.9M274%
Total Cash505M49.1M1,029%
Total Debt140M19.7M711%
TECHNICAL ANALYSIS
Technical Analysis
ABCLOABI
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
64%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
49%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
OABI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSAKX24.600.28
+1.15%
Goldman Sachs International Eq Inc A
DAEMX20.980.21
+1.01%
Dunham Emerging Markets Stock A
CSCCX23.520.11
+0.47%
Calvert Small-Cap C
CUSEX41.400.14
+0.34%
Capital Group US Equity
FLCNX37.20N/A
N/A
Fidelity Contrafund K6

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+0.70%
VCYT - OABI
37%
Loosely correlated
+1.24%
ABCL - OABI
36%
Loosely correlated
-2.16%
NKTX - OABI
36%
Loosely correlated
+7.69%
INMB - OABI
35%
Loosely correlated
+7.41%
TRDA - OABI
35%
Loosely correlated
-0.39%
More